J. Safra Sarasin Holding AG Trims Stake in Colgate-Palmolive Company $CL

31 Mar 2026, 09:52 by Michael Walen · The Markets Daily

J. Safra Sarasin Holding AG cut its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 8.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 675,344 shares of the company’s stock after selling 64,164 shares during the quarter. J. Safra Sarasin Holding AG owned approximately 0.08% of Colgate-Palmolive worth $53,366,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Copia Wealth Management purchased a new stake in Colgate-Palmolive in the third quarter valued at approximately $29,000. Cloud Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $30,000. Global Wealth Strategies & Associates grew its position in shares of Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after acquiring an additional 300 shares during the last quarter. Grove Bank & Trust increased its holdings in shares of Colgate-Palmolive by 182.6% in the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares during the period. Finally, Kelleher Financial Advisors acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $35,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CL shares. Piper Sandler increased their price target on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research note on Tuesday, December 9th. Barclays upped their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $100.00 price target on shares of Colgate-Palmolive in a research report on Friday, February 20th. Twelve equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $95.25.

Check Out Our Latest Research Report on Colgate-Palmolive

Insider Activity

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 184,683 shares of company stock worth $17,486,693 in the last three months. 0.41% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $85.59 on Tuesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The firm has a market cap of $68.67 billion, a price-to-earnings ratio of 32.67, a price-to-earnings-growth ratio of 3.78 and a beta of 0.28. The firm’s fifty day moving average price is $91.13 and its 200 day moving average price is $83.39. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be given a $0.53 dividend. The ex-dividend date is Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive’s payout ratio is 79.39%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.